Literature DB >> 11123423

Critical role of extracellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-induced cell death.

S Osada1, B I Carr.   

Abstract

In the present study, we show that 2-(2-hydroxyethylsulfaryl)-3-methyl-1,4-naphthoquinone, or CPD 5, is a potent growth inhibitor for pancreas cancer cell lines (ID(50): 21.4 +/- 3.8, 31.8 +/- 2.7 and 55.2 +/- 4.5 microM for MiaPaCa, Panc-1 and BxPc3, respectively). It induced protein tyrosine phosphor-ylation of hepatocyte growth factor (HGF) receptor (c-Met) or epidermal growth factor receptor (EGFR), which increased progressively to a maximum level at 30 min in Panc-1 cells. The receptor phosphorylation by CPD 5 was indicated to be functional, since these receptors were found to bind with Grb2 or SOS1 protein. CPD 5 was also suggested to induce phosphorylation of external signal-regulated kinase (ERK). EGF induced cell proliferation through ERK phosphorylation, since U0126, which is an inhibitor of ERK phosphorylation, abrogated the increase of cyclin D1 by EGF. HGF increased the amount of p27 protein, suggesting that it is associated with cell differentiation. By contrast, U0126 reduced CPD 5-induced cell death. On two-dimensional electrophoresis, we found an extra type of phospho-ERK, and this was completely and selectively abolished by U0126. These results suggest that ERK phosphorylation, especially the extra spot on two-dimensional gel, is critically associated with CPD 5-mediated cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123423      PMCID: PMC5926301          DOI: 10.1111/j.1349-7006.2000.tb00911.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  30 in total

Review 1.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

2.  Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs. Significance of protein tyrosine phosphatase inhibition.

Authors:  Y Nishikawa; Z Wang; J Kerns; C S Wilcox; B I Carr
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

3.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

Authors:  M Verheij; R Bose; X H Lin; B Yao; W D Jarvis; S Grant; M J Birrer; E Szabo; L I Zon; J M Kyriakis; A Haimovitz-Friedman; Z Fuks; R N Kolesnick
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

4.  Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.

Authors:  P Chardin; J H Camonis; N W Gale; L van Aelst; J Schlessinger; M H Wigler; D Bar-Sagi
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

5.  Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient.

Authors:  M E Gross; M A Zorbas; Y J Danels; R Garcia; G E Gallick; M Olive; M G Brattain; B M Boman; L C Yeoman
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

Review 6.  Treatment of pancreatic cancer: current limitations, future possibilities.

Authors:  A W Blackstock; A D Cox; J E Tepper
Journal:  Oncology (Williston Park)       Date:  1996-03       Impact factor: 2.990

Review 7.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer.

Authors:  R H Janes; J E Niederhuber; J S Chmiel; D P Winchester; K C Ocwieja; J H Karnell; R E Clive; H R Menck
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

9.  Growth inhibition of hepatoma cells induced by vitamin K and its analogs.

Authors:  Y Nishikawa; B I Carr; M Wang; S Kar; F Finn; P Dowd; Z B Zheng; J Kerns; S Naganathan
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  2 in total

Review 1.  c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer.

Authors:  Daniel Delitto; Eva Vertes-George; Steven J Hughes; Kevin E Behrns; Jose G Trevino
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Novel strategy with gemcitabine for advanced pancreatic cancer.

Authors:  Shuji Komori; Shinji Osada; Kazuhiro Yoshida
Journal:  ISRN Oncol       Date:  2011-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.